TML has acquired the Hologic Cervista HTA (High Throughput Automation) system and the Hologic Gen-Probe Panther.
The HTA system is FDA approved and automates the DNA extraction and detection steps of the Hologic Cervista HR HPV test. The HTA provides higher throughput, improved chain of custody, and accurate results.
The Hologic Gen-Probe Panther is a fully-automated, random access sampling instrument which is currently FDA approved to perform the Aptima CT/NG test and the new Trichomonas vaginalis nucleic acid amplification test. A single one milliliter aliquot from a patient’s Thin Prep Pap Test vial can be tested for up to three different assays simultaneously on the Panther.
FDA approval is currently pending for the Aptima HPV test. A genotyping assay for HPV 16, 18, 45 and HSV-1 and HSV-2 assays are currently in development.